The polyomavirus middle T antigen (PyMT) is an oncogene that activates the non-receptor tyrosine kinase, c-Src, and physically interacts with Taz (WWTR1). Taz is a pro-oncogenic transcription coactivator of the Tead transcription factors. The Hippo tumor suppressor pathway activates the kinase Lats, which phosphorylates Taz, leading to its nuclear exclusion and blunting Tead coactivation. We found that Taz was required for transformation by PyMT, but counter-intuitively, Taz was exclusively cytoplasmic in the presence of PyMT. We demonstrate that in the presence of PyMT, wild-type Taz was phosphorylated by Lats, in a Src-dependent manner. Consistently, a Lats refractory Taz mutant did not undergo cytoplasmic retention by PyMT. We show that Yap, the Taz paralog, and Shp2 phosphatase were nuclear excluded as well. Our findings describe a noncanonical activation of Lats, and an unprecedented Tead-independent role for Taz and Yap in viral-mediated oncogenesis.
INTRODUCTION
DNA tumor viruses induce cellular proliferation, which often results in cell transformation. A recurring viral strategy for inducing cellular proliferation is the direct inhibition of tumor suppressors, the most ubiquitous targets being p53 or Rb, which regulate apoptosis and the cell cycle, respectively. 1, 2 The polyomavirus (Py) early genes code for a unique middle-sized tumor (T) antigen (PyMT) in addition to the common, small and large T-antigens. 3 PyMT is an oncogene and it is necessary, and in many cases sufficient, for transformation of cells in culture, 4 and in animal models, such as MMTV-PyMT transgenic mice, which ectopically express PyMT and consistently form mammary tumors. 5 At the molecular level, PyMT activates a number of cellular signaling pathways. It interacts with the non-receptor tyrosine kinase, c-Src, 6 which is necessary for PyMT-induced transformation. 7, 8 PyMT activates Src and is phosphorylated by it on several Tyr residues. [9] [10] [11] Each of the PyMT-phosphorylated Tyr residues recruits a cellular signaling protein, such as Shc, PI3K and PLCγ. In addition, two subunits of the PP2A phosphatase are recruited to form a PyMT-signaling complex. 3 The Hippo tumor suppressor pathway is conserved from insects to mammals and regulates organ size by inhibiting cellular proliferation upon high density. 12, 13 The mammalian core Hippo pathway kinases, Mst1/2 and Lats1/2 are activated upon high cell density 12 in a phosphorylation cascade. Activated Lats phosphorylates the downstream effectors of the Hippo pathway, two paralog proteins Yap and Taz (WWTR1; WW-domain containing transcription regulator 1). 14, 15 These proteins are coactivators of transcription, which positively regulate proliferation and epithelial to mesenchymal transition, mainly by association with the Tead family of transcription factors. 16, 17 The kinase Lats phosphorylates Yap and Taz on five and four serine residues, respectively, conforming to an HxRxxS motif. 12, 18 Phosphorylation at positions S127/S89 of Yap/Taz, respectively, creates 14-3-3 proteins recognition sites, which upon binding inhibits Yap/Taz nuclear entry and functions. 19 In addition, Lats-mediated phosphorylation of Yap/Taz S381/S306 residues facilitates their proteasomal degradation. 15, 20 Cytoplasmic retention constitutes the major regulation of the Hippo pathway over its pro-oncogenic effectors, and serves as its major tumor suppressor function. Concomitantly, facilitating Yap/Taz nuclear entry, either by their ectopic expression 21 or knockout of the upstream regulators, such as Mst or Lats, 22 supports proliferation and oncogenesis.
Interestingly, Taz interacts with PyMT via the Taz WW-domain and PyMT N-terminus. 23 The d2-4 Py virus mutant (mutation common to all T-Antigens), lacking three amino acid residues (DRV) at the N-terminus does not bind Taz 23 and some other PyMT-signaling complex members, and is inactive in transforming cells. [24] [25] [26] Recently it was reported that Taz and Yap dominantly regulate the localization of the Shp2 phosphatase through direct physical interaction. 27 It also was reported that Shp2 decreases PyMT transformation of mouse fibroblasts, 28 at least in part due to its function in dephosphorylating and inactivating STAT3.
Initially, we hypothesized that the tumor suppressor Hippo pathway is inactivated by the viral oncogene to ensure cellular transformation. We report here that PyMT-mediated transformation required Taz, but counter-intuitively PyMT induced the Lats pathway rather than inhibiting it. We further show that this transformation was not mediated through an increase in Taz activation of Tead. Finally, we demonstrate that Shp2 was nuclear excluded in the presence of PyMT. Our findings suggest that PyMT activates the kinase Lats in a Src-dependent manner. This process gives rise to Taz cytoplasmic sequestration and subsequently to Shp2 nuclear exclusion, thereby supporting PyMT-induced transformation.
RESULTS

Taz enhances cellular transformation by PyMT
PyMT interacts with Taz, an effector protein of the Hippo tumor suppressor pathway 23 (Supplementary Figure S1A ). PyMT is a viral oncogene, and is sufficient in inducing cellular transformation 4 and (Supplementary Figures S1B-D). Here we asked whether Taz supports PyMT-induced transformation. Using Rat1 cells with Doxycyclin (Dox)-inducible knockdown of Taz (Rat1-shTaz TetOn), we measured the effect of Taz depletion on transformation by PyMT in a focus formation assay (Figure 1a Figure 2E) . These data suggest that Taz, the Hippo pathway effector, supports Rat1 fibroblasts transformation by the PyMT oncogene.
PyMT inhibits Taz and Yap coactivation
Next we asked whether Taz induced the pro-oncogenic Tead target genes, as a mechanism for supporting PyMT-induced transformation. We examined this possibility by measuring Yap and Taz coactivation function using pBS-8xGTIIC-Luc (8xGTIIC), a Tead-luciferase reporter construct. 29 As expected, Taz and Yap induced expression of the reporter plasmid under Tead overexpression (Supplementary Figure S3A ). Furthermore, Lats kinase overexpression inhibited the reporter activity, consistent with its role in excluding Yap and Taz from the nucleus (Supplementary Figure S3B ). Although Taz markedly induced the Tead reporter gene, we were surprised to find that in the presence of PyMT this was not the case, and the reporter activity was even reduced by sevenfold (Figure 2a and Supplementary Figure S3C ). When we followed the kinetics of reporter activation, a peak in transcription coactivation by Taz was observed at day 1.5, which was considerably decreased by PyMT ( Figure 2b ). The d2-4 PyMT mutant, defective in transforming cells, failed to do so (Supplementary Figure S3D ). This mutant poorly binds to PyMTsignaling components including Taz. 23 Furthermore, PyMT repressed Yap function in a similar manner (Figure 2c ). Interestingly, PyMT repressed CTGF expression, an endogenous Tead target gene, as well ( Figure 2d ). PyMT did not decrease Taz protein level (Figure 2e We studied this possibility by establishing a Rat1 stable cell line (Rat1-GFP-Taz), which expressed low levels of GFP-Taz fusion protein. We then followed GFP-Taz localization using confocal microscopy. Infection of Rat1-GFP-Taz cells with an empty retroviral vector displayed homogenous GFP-Taz localization both in the cytoplasm and in the nucleus (Figure 3a ). Remarkably, GFP-Taz was highly accumulated in the cytoplasm, in the presence of PyMT. As Taz is a short-lived protein, the proteasomal inhibitor, MG132, was used to increase Taz level in the cells, yet cytoplasmic sequestration of the accumulated GFP-Taz by PyMT was still evident. Remarkably, PyMT-induced colonies in the Rat1-GFP-Taz reporter line, which represent the late stage of the cellular transformation process, displayed an even more pronounced nuclear exclusion of GFP-Taz (Supplementary Figure S4 ).
Next, we tested the localization of endogenous Yap in Rat1 cells, upon infection with PyMT. Yap immunofluorescent staining was detected mainly in the nucleus upon infection with control vector (Figure 3b ). However, upon infection with PyMT, Yap became predominantly cytoplasmic. In addition, analysis of Yap subcellular localization upon infection with PyMT retroviral vector performed using ImageStream technology, which combines confocal microscopy and fluorescence-activated cell sorting analysis at single-cell resolution, yielded similar results (Supplementary Figure S5) . These data suggest that PyMT promotes cytoplasmic accumulation and nuclear depletion of Taz and Yap.
Physical interaction is dispensable for PyMT-induced Taz and Yap cytoplasmic localization
Physical association may be a mechanism by which PyMT retains Taz in the cytoplasm. To examine this possibility we used a Taz-WW-domain mutant (Taz-WA), in which the second conserved W residue of the WW-domain was mutated to alanine. Coimmunoprecipitation experiments revealed that WT Taz but not Taz-WA mutant bound to PyMT (Figure 4a ). A Rat1-GFP-Taz-WA stable cell line was established and transduced with a PyMTexpressing retroviral vector (pBabe puro). Interestingly, Taz-WA behaved like WT and underwent cytoplasmic retention by PyMT (Figures 4b and c ). These results suggest that direct PyMT-Taz physical interaction is not required for PyMT to deregulate Taz subcellular localization.
The kinase Lats is necessary for PyMT-induced Taz and Yap subcellular localization
Yap and Taz subcellular localization is regulated by Lats phosphorylation (Figure 5a ). To address the question of whether Taz phosphorylation by Lats kinase is required for PyMT to induce cytoplasmic retention, we utilized the Lats kinase refractory GFP-Taz-4SA mutant. 12 As previously reported, Taz-4SA was detected mainly in the nucleus (Figure 5b ). Interestingly, PyMT retroviral transduction did not affect Taz subcellular localization, and GFP-Taz-4SA remained nuclear. In contrast, the wild-type GFP-Taz was localized predominantly in the cytoplasm in the presence of PyMT (Figure 5b ). These data suggest that Lats might be involved in PyMT-induced Taz and Yap cytoplasmic retention.
As shown above (Figure 2a ), PyMT inhibited Taz from coactivating a Tead reporter plasmid. To demonstrate the involvement of Lats kinase in this process, we used a kinase dead Lats mutant (Lats-KM). This mutant is predicted to compete with the endogenous functional Lats and to act as a dominant negative mutant. Remarkably, co-transfection of Lats KD mutant markedly restored Taz coactivation in a dose-dependent manner ( Figure 5c ). These results suggest that PyMT activated Lats in phosphorylating and nuclear excluding Yap and Taz.
PyMT induces Taz and Yap phosphorylation
The possibility that PyMT induces cytoplasmic retention of Taz and Yap through Lats kinase activation predicts that, in the presence of PyMT, Taz and Yap are phosphorylated. To challenge this prediction, we analyzed their phosphorylation state using PhosTag containing gels, which specifically retard migration of phosphorylated proteins in SDS-polyacrylamide gel electrophoresis ( Figure 6 ). The resulting bands, detected by western blot, additively depict discrete Taz phosphorylation. Co-transfection of PyMT with Taz yielded several slow-migrating bands, which correlate to multiple Taz phosphorylation sites (Figure 6a To validate that Lats is the most likely candidate kinase responsible for the phosphorylation events observed in the context of PyMT and Src, we used a phospho-specific antibody detecting the phosphorylated motif for 14-3-3 binding. This motif is located on Taz at S89 and is phosphorylated by Lats. Cotransfecting combinations of PyMT, Src and Lats resulted in hyperphosphorylation of Taz (Figure 6b and Supplementary Figure S6B ). Lats alone was not sufficient to induce an efficient upshifting of Taz. This is rather expected as Lats has to be activated by some upstream components of the Hippo pathway, such as WW45, Mst1/2. Similar results were obtained with Yap by using the YAP-pS127-specific antibody (Figure 6c and Supplementary Figure S6C ).
Finally, we addressed the involvement of all the serine residues reported to be phosphorylated by Lats. We co-transfected HEK293 cells with Taz or Taz-4SA mutant, which is refractory to Lats kinase activity (Figure 6d ). Remarkably, this Taz mutant failed to undergo hyperphosphorylation (Figure 6d ). These data suggest that Src promotes PyMT-mediated activation of Lats, resulting in the phosphorylation of Taz and Yap. Taz predicts, therefore, that Shp2 would be sequestered in the cytoplasm. To test this possibility, we determined localization of Shp2 by subcellular fractionation (Figure 7a ). As expected Shp2 localization was very similar to that of Taz and Yap. Shp2 was more cytoplasmic and less nuclear upon co-transfection with a combination of PyMT, Lats and Src (Figure 7a , compare lanes 7-8 to [11] [12] . In addition, we examined Shp2 localization by transduction of PyMT to NIH3T3 cells (Figure 7b ). Infected cells displayed a change in morphology and yielded a more cytoplasmic localization of Shp2, consistent with PyMT-induced nuclear exclusion of Yap and Taz (Figure 7a ).
The involvement of Shp2 in transformation by PyMT was evaluated using Shp2 mutants. Stable Rat1 lines expressing Shp2-C459S enzymatically inactive mutant and Shp2-E76K constitutively active mutant were established and transfected with PyMT (Figures 7c and d) . Remarkably, inhibition of Shp2 by overexpression of the Shp2-C459S-inactive mutant reduced colony formation by PyMT. In a reciprocal experiment, Shp2-E76K constitutively active mutant expressing Rat1 line (Figure 7c ) displayed increased transformation. These data suggest that Shp2 positively supports PyMT transformation.
Taz WW-domain mutant fails to potentiate PyMT transformation To study the effect of Taz-WA on transformation by PyMT, we transfected Rat1 or Rat1-GFP-WA cells with PyMT and used the focus formation assay to quantify transformation (Figure 7e ).
PyMT-mediated transformation was not significantly increased by the Taz-WA mutant (Figure 7f ), in contrast to wild-type Taz. The disparity in potentiation of PyMT transformation between wildtype Taz and Taz-WA suggests a role for the WW-domain in potentiating transformation. We have shown that Taz WW-domain mutant, Taz-WA, undergoes cytoplasmic retention similar to WT Taz, in the presence of PyMT (Figure 4 ). However, Taz-WA fails to interact with Shp2, and direct its localization. 27 These data are in agreement with a role for cytoplasmically retained Shp2 in transformation by PyMT.
We propose a model whereby Src supports Lats activation by PyMT, which gives rise to Taz and Yap hyperphosphorylation and cytoplasmic sequestration. This, in turn, mediates sequestration of Shp2 into the cytoplasm where it supports PyMT transformation (Figure 7g ).
DISCUSSION
PyMT is the major oncogene of the Polyomavirus. 31 It serves as a reliable model of transformation, and over the years, a mouse model for breast cancer using PyMT transformation has been implemented as well. 5 PyMT transforms cells in a single-step process, by subjugating multiple signaling molecules such as Shc (MAP kinase pathway), PI3K, PLCY and others, and has often been compared with a constitutively activated growth factor receptor. 32 It is sufficient and in many cases required for transformation of established rodent cells. 4, 33 In addition, PyMT physically interacts with Taz. 23 The Hippo pathway effectors, Taz and its paralog Yap support proliferation when nuclear. We demonstrate here that, counter-intuitively, PyMT induced their cytoplasmic retention. We show that coactivation of Tead by both Taz and Yap is severely hampered in the presence of PyMT. Immunostaining and quantified ImageStream analyses revealed marked Taz and Yap cytoplasmic accumulation. Taz and Yap were not subject to re-entry to the nucleus over time, as monitored by GFP-Taz cytoplasmic localization in fully transformed PyMT-infected cells.
Lats, the core kinase of the Hippo pathway, is known to phosphorylate Taz and Yap at S89 and S127 residues, respectively, to induce 14-3-3 binding and cytoplasmic retention. We found that PyMT induced the Lats-mediated S127/S89 phosphorylation. Band upshift and PhosTag analysis revealed Taz and Yap Supplementary Figure S6B ). (c) HEK293 cells were co-transfected with Yap and indicated constructs. Yap was immunoprecipitated and Lats-dependent phosphorylation state was analyzed by western blot, using the phosphorylated S127 antibody. Dashed bars represent cropped lanes (uncropped image in Supplementary Figure S6C ). (d) Taz phosphorylation-dependent band shift failed to be reproduced by the Lats refractory mutant 4SA. HEK293 cells were co-transfected with indicated constructs, resolved on SDS-PAGE and western blotted using indicated antibodies.
hyperphosphorylation in co-transfection of cells with PyMT, Src and Lats. The increase in Lats phosphorylation intensity was underrepresented using the pS14-3-3-binding-motif and pS127 phosphorylation site antibodies, as only one of several Lats phosphorylation sites was recognized by the phospho-specific antibodies. However, this underrepresentation was compensated by a dramatic upshift in the proteins' migration pattern, the outcome of phosphorylation of additional Lats target residues. 14, 34 When all the known Lats phosphorylation sites on Taz were mutated (Taz-4SA), PyMT failed to induce Taz phosphorylation and cytoplasmic retention.
As the Hippo pathway, along with Lats activation is associated with inhibition of proliferation, the finding that the strong oncogene, PyMT, activates the Lats tumor suppressor in proliferating cells is puzzling. Recently, Yap and Taz were demonstrated to dominantly regulate Shp2 subcellular localization via physical interaction. 27 Indeed, we show that Shp2 is sequestered in the cytoplasm in the presence of PyMT in a Srcdependent manner, just like Taz and Yap.
We provide evidence for a positive role of Shp2 in PyMT transformation of Rat1 cells, summarized in a model (Figure 7g ). We found that constitutively active Shp2 increased, while inactive mutant (C459S) acted as a dominant negative and decreased PyMT-mediated transformation, in contrast to that reported in the context of NIH3T3 cells. 28 This discrepancy is not simple to reconcile. In the NIH3T3 cells, it has been proposed that Shp2 activity has to be diminished to allow STAT3 mediated transformation. As STAT3 is nuclear, a possible mechanism would be Shp2 nuclear exclusion in a Taz dependent manner. As Shp2 is catalytically active, near-to-complete Shp2 nuclear exclusion is needed and therefore Taz/Yap levels have to be in excess over the Shp2 level. Thus, different cell lines and experimental settings can potentially explain the discrepancy.
Finally, active Lats in tumor cells is likely to have phenotypic consequences. It has been reported that PyMT is able to temporarily transform human endothelial cells. 35 When human endothelial cells expressing PyMT were introduced into mice, they formed hemangiomas. These contained not only human cells but also recruited mouse endothelial cells. 36 Endothelial cells expressing PyMT also expressed VE-cadherin, associated with cell-cell contact induced growth inhibition in this cell type, 37 the hallmarks of Lats activation. Furthermore, in vitro analysis of PyMTexpressing endothelial cells reveals that the cells reach confluence without signs of overgrowth, 35 once more consistent with Lats activity. Thus, although activation of the tumor suppressor Lats by PyMT would initially appear to be at odds with cellular transformation, PyMT makes noncanonical use of the Hippo pathway to promote transformation. The unique aspects of this activation offer new insights into the Hippo pathway and its modulation in normal and cancer cells.
MATERIALS AND METHODS
Cell culture
Human embryonic kidney cells (HEK293), HEK293T, and the rat embryonic fibroblasts cell line (Rat1), were cultured in Dulbecco's modified Eagle's medium (GIBCO; Grand Island, NY, USA) supplemented with 8% fetal bovine serum (GIBCO), 100 units/ml penicillin, 100 μg/ml streptomycin and cultured at 37°C in a humidified incubator with 5% CO 2 . MG132 proteasomal inhibitor was used at 25 μM for 1.5 h.
Transfections were done by the calcium phosphate method as previously described in Levy et al. 38 To generate stable cell lines expressing GFP-Taz, GFP-4SA or GFP-WA or Tet-pLKO-On-ShTaz (Rat1-shTaz TetOn stable line), infection was performed by transfecting HEK293T cells with the respective vector and helper plasmid in equal amount. Forty-eight hours after transfection, the supernatant containing the viral particles was filtered through a 0.45-μm filter, supplemented with 8 μg/ml polybrene, and used to infect Rat1 cells. Twenty-four hours after infection, cells were selected with either 2 μg/ml Puromycin (Sigma-aldrich; Rehovot, Israel) or 300 μg/ml Hygromycin B (Calbiochem; Merck Millipore, Billerica, MA, USA) in the culture medium. Plasmids pCDNA3-Flag-mTaz, pCDNA-myc-mTaz and pCDNA-myc-mTazWA were obtained from R Bassel-Duby. pCMV-Yap1 was supplied by M Sudol. pBabe-Puro (pBP) and pBabe-Hygro (pBH) retroviral vectors were previously described. 39 PyMT was re-cloned from pBH-PyMT (Addgene, Cambridge, MA, USA, plasmid #22305), into pBP with a C-terminal HA-tag, resulting in pBP-PyMT-HA. pBH-GFP-mTaz and pBH-GFP-mTaz-WA were generated by cloning GFP from pEGFP-N1 in frame with mTaz from pCDNA3-Flag-mTaz or pCDNA3-myc-Taz-WA. pBP-GFP-hTaz-4SA was a gift from J Zhang. Taz shRNA targeting the sequence 5′-ATGAATCCGTCC TCGGTG-3′ was cloned into the Tet-pLKO-Puro inducible vector (Addgene plasmid #21915) to create Tet-pLKO-Puro-shTaz. The pBS-8xGTIIC-Luc (8xGTIIC) Tead reporter was obtained from H Sasaki. The mSrc sequence was obtained from A Elson, and cloned into pCDNA3. Src sequence was mutated by PCR to produce the constitutively active Src-Y527 and cloned into pCDNA3. HA-tagged Lats2, Lats-KM, Mst1, and WW45 constructs were obtained from XJ Yang. Myc-tagged human Lats2 constructs were from M Oren. pBP-Shp2 C459S and pBP-Shp2-E76K were provided by B Neel.
Immunoblot and coimmunoprecipitation studies
Immunoblots and immunoprecipitations were done as previously described. 38 The antibodies used were: anti-HA (BAbCo; Richmond, CA, USA), anti-actin (Sigma-Aldrich), anti-myc antibody (9E10; Weizmann Institute, Rehovot, Israel), anti-Flag M2 and M5 (Sigma-Aldrich), anti-Yap antibody (H-125, Santa Cruz Biotechnology; Santa Cruz, CA, USA), anti-c-Jun antibody (Santa Cruz Biotechnology, H-79), anti-tubulin (Sigma-Aldrich), anti-LaminB (Santa Cruz Biotechnology, M-20) anti v-Src (Calbiochem, Ab-1). For immunoprecipitation of Flag-tagged, HA-tagged or myc-tagged proteins, anti-Flag M2 conjugated agarose beads (Sigma-Aldrich), anti-HA conjugated agarose beads (Sigma-Aldrich) or A/G agarose beads (Santa Cruz Biotechnology) loaded for 2 h with anti-myc antibody were used, respectively. Phosphorylation analysis by PhosTag gels, was done by the addition of 10 mM PhosTag (Wako Chemicals GmbH; Neuss, Germany) to 6% polyacrylamide gels before casting. Horseradish peroxidase-conjugated secondary antibodies were from Jackson Laboratories (West Grove, PA, USA). Enhanced chemiluminescence was performed with the EZ-ECL kit (Biological Industries; Kibbutz Beit Haemek, Israel) and signals were detected by the ImageQuant LAS 4000 (GE Healthcare; Piscataway, NJ, USA).
Real-time PCR
Total RNA was extracted using the PerfectPure RNA cultured cell kit (5prime) and then reverse-transcribed by iScript cDNA synthesis kit (Bio-Rad; Hercules, CA, USA). Quantitative PCR with reverse transcription was performed with SYBR Green PCR Master Mix (Kapa Biosystems; Woburn, MA, USA) using the LightCycler 480 Instrument (Roche Diagnostics; Basel, Switzerland). Sequences of the oligos were as follows: rTBP forward 5′-CCCTATCACTCCTGCCACCAGC-3′, reverse 5′-GTGCAATGGTCTTTAGGTAGTT TACAGCC-3′, and rCTGF forward 5′-CCCTAGCTGCCTACCGACT-3′ and reverse 5′-TGGCTCGCATCATAGTTGGG-3′.
Focus formation assay
Rat1 cells were transfected with pCDNA3-PyMT-HA or control vector using the calcium phosphate method. Growth medium was replaced every 2-3 days, until colonies appeared (~14 days). Cells were then washed with phosphate-buffered saline (PBS) and fixed with ice-cold methanol for 15 min. Cells were then briefly stained with 0.1% Crystal violet in 25% methanol, at room temperature, then rinsed with double distilled water until staining no longer washed out. Expression of shRNA from Rat1-shTaz-TetOn stable line was induced with Doxycyclin (Sigma-Aldrich) at concentrations between 50 ng/ml and 1 μg/ml.
Cellular fractionation
Subcellular fractionation procedure modified from ref. 40 was performed as follows. Cells were suspended in hypotonic buffer (10 mM HEPES KOH pH = 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM DTT and protease inhibitors mixture) for 5 min on ice and then homogenized in a prechilled glass Dounce homogenizer by 15-20 strokes. The homogenate was centrifuged for 5 min at 1000 g. The supernatant was collected as a cytoplasmic extract. Pellet was washed three times and resuspended in nuclear extraction buffer (20 mM HEPES KOH pH = 7.9, 420 mM NaCl, 1.5 mM MgCl 2 , 25% glycerol, 0.2 mM EDTA, 0.5% NP-40, 0.1% DOC, 0.1% Brij 0.5 mM DTT and protease inhibitors mixture). After 10 min incubation on ice, the suspension was centrifuged for 15 min at 16 000 g, and the supernatant was collected as the nuclear fraction.
Reporter gene assays HEK293 cells were transfected with plasmids expressing the tested constructs along with a promoter-containing firefly luciferase reporter plasmid, and a Renilla luciferase-expressing plasmid as a transfection control. Twenty-four to thirty-six hours after transfection, cell lysates were analyzed for luciferase activity in the Modulus microplate multimode reader (Turner Biosystems; Sunnyvale, CA, USA), and differences in transfection efficiency were corrected for by normalizing the firefly luciferase activity to that of Renilla luciferase. Real-time bioluminescence recordings were performed with a LumiCycle machine (Actimetrics, Wilmette, IL, USA).
Immunofluorescence and microscopy
Rat1 cells were seeded onto 18 mm glass cover slips and infected as indicated above. Cells were cultured an additional 48 h, then fixed in 4% paraformaldehyde at room temperature for 30 min, then permeabilized for 20 min using 0.1% Triton X-100 in PBS. Coverslips were blocked (90% FBS, 10% skimmed milk and 0.02% Tween-20) for 1 h at room temperature, then incubated with primary antibodies for 1 h at room temperature. Primary antibodies, Yap (Rabbit, H-125, 1:100, Santa Cruz Biotechnology), HA (mouse, BAbCo, 1:800), Shp2 (rabbit, C-18, 1:100, Santa Cruz Biotechnology) were diluted in 10% skimmed milk/PBS solution. Next, cover slips were rinsed with PBST (PBS, 0.02% Tween-20) six times. Secondary antibodies were conjugated to Alexa Fluor 555 (goat antimouse, Invitrogen, Life Technologies, Carlsbad, CA, USA) or Alexa Fluor 488 (goat anti-rabbit, Invitrogen). Coverslips were then washed with PBST six times. Next, cover slips were mounted onto glass slides using Fluoromount G (Southern Biotech; Birmingham, AL, USA), containing 4′,6-diamidino-2phenylindole nuclear staining. Images of immunofluorescence were acquired using a Zeiss LSM 710 or LSM 510 confocal scanning system, using × 63 NA (numerical aperture) 1.4 objectives, and processed using Adobe Photoshop CS6 and Adobe Illustrator CS6.
Statistical analysis
All values presented in graphs represent the average of at least three independent experiments. To estimate distribution of values, standard error of the mean was calculated. The two-tailed student t-test was used to verify statistical significance in the difference between relevant values.
The Fisher's exact test was used to determine statistical significance of category distribution.
